Marksans Pharma
MARKSANS •NSE

Marksans Pharma

₹294.50-11.60 (3.79%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
291.30
Today’s high
315.55
52 week low
155.00
52 week high
350.95
Open price
306.20
Previous close
306.10
Live volume
14,16,190
Lower circuit
235.60
Upper circuit
353.40

Fundamentals

Market Cap
₹13,386Cr
ROE
16.80%
P/E Ratio(TTM)
23.67
EPS(TTM)
12.48
P/B Ratio
4.02
Dividend Yield
0.30%
Industry P/E
40.12
Book Value
73.53
Debt to Equity
0.14
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹958Cr
+10.63%
₹144Cr
-9.96%
02505007501k
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+29%
3Y CAGR+17%
Profit growthValue
1Y (TTM)+45%
3Y CAGR+17%

About

Marksans Pharma is a trusted global pharmaceutical company that develops, manufactures, and distributes both over-the-counter (OTC) and prescription (Rx) drugs for regulated markets. Its guiding vision is to transform into a respected, profitable, and integrated global pharmaceutical enterprise by delivering quality formulations to people. The company's overall manufacturing capacity has impressively reached 26 billion units per year, a fourfold increase achieved over several years.;
CEO/MD
Mark Saldanha
Founded in
1992
NSE symbol
MARKSANS
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹3,841.80
+27.80 (0.73%)
L
    H
    17,589.0920.474.01
    Natco PharmaNATCOPHARM
    ₹820.60
    -2.30 (0.28%)
    L
      H
      16,093.6219.41.46
      ₹2,085.30
      -161.80 (7.20%)
      L
        H
        15,853.0022.644.06
        ₹6,043.50
        -124.50 (2.02%)
        L
          H
          15,017.3884.517.09
          Livesquawk •
          Marksans Pharma reports Q2 consolidated net profit of ₹1.5B, up from ₹983M a year earlier. The quarterly performance indicates strong year-on-year net profit growth for the company.
          Livesquawk •
          Marksans Pharma schedules analyst and investor meet on Sep 2. Details of the discussion remain undisclosed in the update.
          2026
          4
          Nov
          Quarterly Result
          Release date

          20
          Aug
          Dividend
          Ex date
          ₹0.90
          per share

          For each share you hold, you will receive ₹0.90
          Dividend amount₹0.90 per share
          Dividend TypeFinal
          Ex Date20 Aug ‘26
          Record Date20 Aug ‘26
          Announcement date26 May ‘26
          12
          Aug
          Quarterly Result
          Release date

          26
          May
          Dividend
          Announced
          ₹0.90
          per share

          For each share you hold, you will receive ₹0.90
          Dividend amount₹0.90 per share
          Dividend TypeFinal
          Ex Date20 Aug ‘26
          Record Date20 Aug ‘26
          Announcement date26 May ‘26
          26
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date

          1
          Aug
          Dividend
          Ex date
          ₹0.80
          per share

          For each share you hold, you will receive ₹0.80
          Dividend amount₹0.80 per share
          Dividend TypeFinal
          Ex Date1 Aug ‘25
          Record Date1 Aug ‘25
          Announcement date19 May ‘25

          19
          May
          Dividend
          Announced
          ₹0.80
          per share

          For each share you hold, you will receive ₹0.80
          Dividend amount₹0.80 per share
          Dividend TypeFinal
          Ex Date1 Aug ‘25
          Record Date1 Aug ‘25
          Announcement date19 May ‘25
          Events calendar
          View upcoming events in other stocks